Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
CytomX Therapeutics Inc
Swot
CytomX Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
CytomX Therapeutics Inc has 10 Strengths, 7 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(7)
Opportunity
(1)
Threats
(2)
Others
(2)
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Relative Outperformance versus Industry over Half Year (6 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Highest Recovery from 52 Week Low
Negative Breakdown First Support (LTP < S1)
PE higher than Industry PE
Top Losers
Negative Breakdown First Support (LTP < S1)
Profit to Loss Companies
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
